Brixadi (buprenorphine) is a brand-name injection that’s prescribed for opioid use disorder. As with other drugs, Brixadi can cause side effects, such as injection site reactions and respiratory ...

Keep reading for specific information about the dosage of Brixadi, including its strengths and how the medication is given. For a comprehensive look at Brixadi, see this article. Note: This article ...

Brixadi (buprenorphine) is a prescription drug that’s used to treat opioid use disorder (OUD). Brixadi comes as a liquid solution in a prefilled syringe. You’ll receive Brixadi as an injection under ...

Credit: Braeburn. Brixadi (weekly) and Brixadi (monthly) are different formulations. Brixadi ® (buprenorphine) extended-release subcutaneous injection is now available for the treatment of moderate to ...

As the United States' opioid epidemic rages on, health officials are busy looking for ways to help with the response. Now, right on the heels of the FDA's approval for a new overdose rescue medication ...

Brixadi will be supplied as weekly (8mg, 16mg, 24mg, 32mg) and monthly (64mg, 96mg, 128mg) injections. The tentative approval means the FDA concluded Brixadi met all the required safety, efficacy, and ...

The FDA tentatively approved certain Brixadi injections for treatment of moderate to severe opioid use disorder, according to a press release from Braeburn, the drug manufacturer. Brixadi ...

LUND, Sweden, June 26, 2021 /PRNewswire/ — Camurus (NASDAQ STO: CAMX) announced today that the New Drug Application (NDA) by Camurus’ US licensee Braeburn for BrixadiTM (buprenorphine) ...

LUND, Sweden, June 15, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX) today announced that its US licensee Braeburn has resubmitted the New Drug Application (NDA) for Brixadi 1 (buprenorphine) ...

In this part of his Pharmaceutical Executive video interview, Joshua M. Cohen, MD, MPH, FAHS, Chief Medical Officer, Braeburn discusses data from the Phase III trial recently published in JAMA and how ...

Brixadi (buprenorphine) is a prescription drug used to treat opioid use disorder in adults. Brixadi can cause side effects that range from mild to serious. Examples include headache, constipation, and ...